HighQC™ IPSC (KO) LRRK2-/-, Parkinson’s Disease (PD), Biallelic KO
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
The ABC-SC095G iPSC line is engineered with a bi-allelic (homozygous) knockout for LRRK2 gene (PARK2-/-) that has been implicated in Parkinson’s disease. The parental iPSC is ABC-SC096G which is an integration-free, normal karyotype iPSC derived from male fibroblasts. The LRRK2 knockout line can be further differentiated into an isogenic panel of neurons and glia for disease modeling and drug/toxicity screening applications.
Species | Human |
Cat.No | ABC-SC095G |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Stem Cells |
Size/Quantity | 1 vial |
Cell Type | Stem Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Skin Fibroblasts |
Disease | Parkinson’s Disease |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Human iPSCs |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only